Skip to main content
Login
Contact
Subscribe
Search form
Search
The Decatur Daily Democrat
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Photos
Videos
Games
Entertainment
Local Guide
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Axsome Thera
(NQ:
AXSM
)
90.34
USD
-2.14 (-2.31%)
Official Closing Price
/ Updated:
7:58 PM EST, Jan 17, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
469,400
Open
92.99
Bid (Size)
89.00 (2)
Ask (Size)
91.33 (1)
Prev. Close
92.48
Today's Range
89.51 - 93.50
52wk Range
7.630 - 109.94
Shares Outstanding
25,685,492
Dividend Yield
N/A
Performance
YTD
-10.83%
-10.83%
1 Month
-8.51%
-8.51%
3 Month
+310.26%
+310.26%
6 Month
+243.37%
+243.37%
1 Year
+960.33%
+960.33%
Top News
More News
Global Brain Tumor Drugs Market Expected To Exceed $3 Billion Through 2022
January 14, 2020
category
Featured News
from
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Brain Tumor Drugs Market Expected to Exceed $3 Billion Through 2022
January 14, 2020
Financialnewsmedia.com News Commentary
Read More
from
PR Newswire
More News
Read More
Axsome Therapeutics Enters into Exclusive License Agreement with Pfizer Inc. for Pfizer’s Reboxetine Clinical and Nonclinical Data and for New Phase 3 Esreboxetine Product Candidate
January 13, 2020
from
GlobeNewswire News Releases
Looking For Penny Stocks To Buy? These 3 Crushed It In 2019
December 30, 2019
from
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Are Biotech Stocks Due for a Correction in 2020?
January 15, 2020
category
SGEN
,
VRTX
,
AXSM
, and 3 more.
from
Motley Fool
Thinking about buying stock in Apple, Axsome Therapeutics, Crocs, Lululemon Athletica, or Tilray?
January 13, 2020
from
PR Newswire
2 Top Growth Stocks to Buy in January
January 15, 2020
category
INCY
,
SAGE
,
Market News
, and 1 more.
from
Motley Fool
The 10 Best-Performing Micro-Cap Stocks of 2019
January 11, 2020
category
Pharma/Biotech
from
Blogs - TalkMarkets
2 Small-Cap Stocks With Big-Cap Potential
January 08, 2020
category
TGTX
,
Market News
,
AXSM
, and 1 more.
from
Motley Fool
Noteworthy ETF Inflows: DWAS, AXSM, GMRE, KOD
January 03, 2020
category
ETFs
from
ETF Channel
The 10 Best Healthcare Stocks of the Decade
January 07, 2020
category
SLP
,
NEO
,
AXDX
, and 10 more.
from
Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
